
BAT has already started pre-clinical testing on animals, of a plant-based vaccine via US biotech subsidiary Kentucky BioProcessing. Philip Morris, on the other hand, through its partially-owned Canadian unit Medicago, expects to start human trials of a potential vaccine this summer.
from International-News-Economic Times https://ift.tt/39ALxlR
via
IFTTT
0 comments:
Post a Comment